Stay updated on T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-19T19:06:36.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T08:09:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T05:43:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:46:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T01:36:51.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 13, 2025.
    Difference
    1.0%
    Check dated 2025-04-08T20:09:04.000Z thumbnail image

Stay in the know with updates to T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1 & Tucatinib in HER2+ Breast Cancer Clinical Trial page.